D-Dimer Levels and Disease Prognosis in COVID-19 Patients

Elevated or abnormal levels of coagulation parameters indicate thrombotic disorders that need to be managed at the earliest to prevent complications and reduce mortality in coronavirus disease (COVID-19) patients. D-dimer is a product that is a part of fibrin abasement, which can be used as a test f...

Full description

Bibliographic Details
Main Authors: Manisha Khandait, Ishi Sharma, Rakesh Pandit
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2021-06-01
Series:Journal of Pure and Applied Microbiology
Subjects:
Online Access:https://microbiologyjournal.org/d-dimer-levels-and-disease-prognosis-in-covid-19-patients/
_version_ 1819137189094621184
author Manisha Khandait
Ishi Sharma
Rakesh Pandit
author_facet Manisha Khandait
Ishi Sharma
Rakesh Pandit
author_sort Manisha Khandait
collection DOAJ
description Elevated or abnormal levels of coagulation parameters indicate thrombotic disorders that need to be managed at the earliest to prevent complications and reduce mortality in coronavirus disease (COVID-19) patients. D-dimer is a product that is a part of fibrin abasement, which can be used as a test for the diagnosis of thrombotic disorders. Higher D-dimer levels are a strong indicator of mortality in patients with active COVID-19. This study aimed to determine the relationship between D-dimer levels and the clinical prognosis of COVID-19 patients. This observational, prospective study was conducted between April 2020 and September 2020. All patients with COVID-19 infection were considered for this study, along with their D-dimer values. Patients with higher D-dimer levels and pre-existing morbidities experienced a longer hospital stay and increased complications when compared to patients without pre-existing morbidities. Abnormally elevated D-dimer levels were frequently observed upon admission due to COVID-19 and are analogous to the increased occurrence of critical illness, thrombotic events, acute kidney injury, and death. Therefore, D-dimer levels could be a valuable clinical biomarker and an important indicator of prognosis for patients with COVID-19 with pre-existing morbidities.
first_indexed 2024-12-22T10:46:55Z
format Article
id doaj.art-32753ed5d9294b5da3e4464507c58dab
institution Directory Open Access Journal
issn 0973-7510
2581-690X
language English
last_indexed 2024-12-22T10:46:55Z
publishDate 2021-06-01
publisher Journal of Pure and Applied Microbiology
record_format Article
series Journal of Pure and Applied Microbiology
spelling doaj.art-32753ed5d9294b5da3e4464507c58dab2022-12-21T18:28:54ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2021-06-0115281982510.22207/JPAM.15.2.36D-Dimer Levels and Disease Prognosis in COVID-19 PatientsManisha Khandaithttps://orcid.org/0000-0003-4441-1656Ishi Sharmahttps://orcid.org/0000-0001-6096-2840Rakesh Pandithttps://orcid.org/0000-0002-6822-1059Elevated or abnormal levels of coagulation parameters indicate thrombotic disorders that need to be managed at the earliest to prevent complications and reduce mortality in coronavirus disease (COVID-19) patients. D-dimer is a product that is a part of fibrin abasement, which can be used as a test for the diagnosis of thrombotic disorders. Higher D-dimer levels are a strong indicator of mortality in patients with active COVID-19. This study aimed to determine the relationship between D-dimer levels and the clinical prognosis of COVID-19 patients. This observational, prospective study was conducted between April 2020 and September 2020. All patients with COVID-19 infection were considered for this study, along with their D-dimer values. Patients with higher D-dimer levels and pre-existing morbidities experienced a longer hospital stay and increased complications when compared to patients without pre-existing morbidities. Abnormally elevated D-dimer levels were frequently observed upon admission due to COVID-19 and are analogous to the increased occurrence of critical illness, thrombotic events, acute kidney injury, and death. Therefore, D-dimer levels could be a valuable clinical biomarker and an important indicator of prognosis for patients with COVID-19 with pre-existing morbidities.https://microbiologyjournal.org/d-dimer-levels-and-disease-prognosis-in-covid-19-patients/covid-19coronavirusd-dimerhypercoagulationprognosismortality
spellingShingle Manisha Khandait
Ishi Sharma
Rakesh Pandit
D-Dimer Levels and Disease Prognosis in COVID-19 Patients
Journal of Pure and Applied Microbiology
covid-19
coronavirus
d-dimer
hypercoagulation
prognosis
mortality
title D-Dimer Levels and Disease Prognosis in COVID-19 Patients
title_full D-Dimer Levels and Disease Prognosis in COVID-19 Patients
title_fullStr D-Dimer Levels and Disease Prognosis in COVID-19 Patients
title_full_unstemmed D-Dimer Levels and Disease Prognosis in COVID-19 Patients
title_short D-Dimer Levels and Disease Prognosis in COVID-19 Patients
title_sort d dimer levels and disease prognosis in covid 19 patients
topic covid-19
coronavirus
d-dimer
hypercoagulation
prognosis
mortality
url https://microbiologyjournal.org/d-dimer-levels-and-disease-prognosis-in-covid-19-patients/
work_keys_str_mv AT manishakhandait ddimerlevelsanddiseaseprognosisincovid19patients
AT ishisharma ddimerlevelsanddiseaseprognosisincovid19patients
AT rakeshpandit ddimerlevelsanddiseaseprognosisincovid19patients